Crystec has been shortlisted in the Sustainability in Manufacture category at the Making Pharmaceuticals awards. This is Crystec’s second award nomination in the area of sustainability this year following our nomination for the 2024 Bionow awards. Crystec’s nomination is for Modified Supercritical Anti-Solvent (mSAS®) Particle Engineering Platform for Green Pharmaceutical Manufacturing. Read more about Crystec’s nomination here.
The event features a conference, networking and an exhibition and covers all aspects of the pharmaceutical supply chain in the UK and Ireland.
The awards dinner will take place on 29 April from 7pm-11pm at the Coventry Building Society Arena.
